Clinical Trial Update: Lesinurad and Allopurinol Combination Extension Study in Gout [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 extension trial evaluating the combination of lesinurad with allopurinol for gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Allopurinol (Allopurinol)
• Zurampic (lesinurad)

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 3 | Status: COMPLETED